NovoCure Ownership | Who Owns NovoCure?

Overview Forecast RevenueFinancials Chart Transcripts

NovoCure Ownership Summary

NovoCure is owned by 85.81% institutional investors, 9.26% insiders, and 4.94% retail investors. Fmr is the largest institutional shareholder, holding 15.05% of NVCR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.94% of its assets in NovoCure shares.

NVCR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	NovoCure	85.81%	9.26%	4.94%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Medical Instruments & Supplies Stocks	57.74%	11.38%	30.88%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	16.14M	15.05%	$276.51M
Blackrock	12.13M	11.31%	$207.83M
Capital investors	11.70M	10.90%	$200.36M
Vanguard group	11.13M	10.37%	$190.61M
State street	3.01M	2.80%	$51.49M
Geode capital management	2.38M	2.21%	$40.70M
Capital world investors	2.31M	2.15%	$39.54M
Price t rowe associates inc /md/	2.16M	2.01%	$36.93M
T. rowe price investment management	1.71M	1.60%	$29.33M
Baillie gifford	1.69M	1.57%	$28.91M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nordwand advisors	1.51M	11.32%	$25.95M
Invus financial advisors	350.88K	6.74%	$6.01M
Superstring capital management lp	66.89K	1.44%	$1.15M
Palo alto investors lp	561.91K	1.12%	$9.63M
Taylor frigon capital management	133.30K	1.09%	$2.28M
Essex investment management	161.49K	0.52%	$2.77M
Birchview capital, lp	20.00K	0.32%	$342.60K
Pdt partners	188.42K	0.31%	$3.23M
Frontier capital management	1.03M	0.17%	$17.62M
Alpha dna investment management	20.35K	0.14%	$348.65K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	12.13M	0.00%	3.05M
Capital investors	11.70M	0.04%	2.83M
T. rowe price investment management	1.71M	0.02%	1.71M
Vanguard group	11.13M	0.00%	1.10M
Geode capital management	2.38M	0.00%	732.25K

Top Sellers

Holder	Shares	% Assets	Change
Morgan stanley	806.52K	0.00%	-950.12K
Cubist systematic strategies	354.03K	0.04%	-559.77K
Rhenman & partners asset management ab	-	-	-495.31K
Jacobs levy equity management	-	-	-475.23K
Qube research	322.51K	0.01%	-467.85K

New Positions

Holder	Shares	% Assets	Change	Value
T. rowe price investment management	1.71M	0.02%	1.71M	$29.33M
Silvercrest asset management group	385.41K	0.05%	385.41K	$6.60M
Essex investment management	161.49K	0.52%	161.49K	$2.77M
Superstring capital management lp	66.89K	1.44%	66.89K	$1.15M
Corebridge financial	57.29K	0.01%	57.29K	$982.02K

Sold Out

Holder	Change
Salem investment counselors	-4.00
Mather group, llc.	-15.00
Central trust	-18.00
Tfc financial management	-19.00
Raleigh capital management	-26.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	234	-6.02%	92,882,050	-0.04%	85	1.14%	91	-26.61%	73	7.35%
Jun 30, 2024	247	-4.26%	92,913,219	4.09%	86	1.23%	123	-1.60%	67	6.35%
Mar 31, 2024	258	7.05%	89,258,298	-1.39%	83	1.17%	125	-2.34%	63	12.50%
Dec 31, 2023	241	-5.12%	90,513,161	-0.77%	84	1.15%	128	5.79%	56	-11.11%
Sep 30, 2023	254	-12.41%	91,218,726	0.53%	85	1.16%	121	9.01%	63	-33.68%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	7.50M	6.94%	43.30K
Fidelity Growth Compy Commingled Pl O	7.46M	6.89%	-
American Funds SMALLCAP World A	6.52M	6.03%	2.00M
Fidelity Growth Company Fund	5.30M	4.90%	-11.25K
Vanguard Total Stock Mkt Idx Inv	3.40M	3.14%	-20.45K
Capital Group Growth Fnd of Amer Comp	3.30M	3.05%	-
American Funds Growth Fund of Amer A	3.30M	3.05%	-
iShares Russell 2000 ETF	2.74M	2.53%	-6.16K
Vanguard Small Cap Index	2.72M	2.51%	5.30K
Fidelity Growth Company K6	1.85M	1.71%	-31.88K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 02, 2024	Paravasthu Mukund	Chief Operating Officer	Sell	$734.18
Oct 31, 2024	Puri Michal Nath	Chief Human Resources Officer	Sell	$12.79K
Nov 01, 2024	Leonard Frank X	EVP, Pres., Novocure Oncology	Sell	$9.53K
Nov 01, 2024	Paravasthu Mukund	Chief Operating Officer	Sell	$2.54K
Aug 02, 2024	Cordova Ashley	Chief Financial Officer	Sell	$13.86K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	4
2024 Q3	-	1
2024 Q2	-	3
2024 Q1	-	6
2023 Q4	-	1

NVCR Ownership FAQ

Who Owns NovoCure?

NovoCure shareholders are primarily institutional investors at 85.81%, followed by 9.26% insiders and 4.93% retail investors. The average institutional ownership in NovoCure's industry, Medical Instruments & Supplies Stocks, is 57.74%, which NovoCure exceeds.

Who owns the most shares of NovoCure?

NovoCure’s largest shareholders are Fmr (16.14M shares, 15.05%), Blackrock (12.13M shares, 11.31%), and Capital investors (11.7M shares, 10.90%). Together, they hold 37.26% of NovoCure’s total shares outstanding.

Does Blackrock own NovoCure?

Yes, BlackRock owns 11.31% of NovoCure, totaling 12.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 207.83M$. In the last quarter, BlackRock increased its holdings by 3.05M shares, a 33.55% change.

Who is NovoCure’s biggest shareholder by percentage of total assets invested?

Nordwand advisors is NovoCure’s biggest shareholder by percentage of total assets invested, with 11.32% of its assets in 1.52M NovoCure shares, valued at 25.95M$.

Who is the top mutual fund holder of NovoCure shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of NovoCure shares, with 6.94% of its total shares outstanding invested in 7.5M NovoCure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools